课题基金 / 基金详情

Evaluation of biological characteristics in tumor vessels and clinical application of antagonistic agent for neovascularization

Evaluation of biological characteristics in tumor vessels and clinical application of antagonistic agent for neovascularization
肿瘤血管生物学特性评价及新生血管拮抗剂的临床应用
批准号:
07457257
负责人:
KANEMATSU Takashi
金额:
$1.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997

项目摘要

项目成果

KANEMATSU Takashi的其他基金

相似基金

相关文献

中文摘要
翻译
背景近年来,有报道称某些致癌促进剂具有血管生成活性,而维甲酸及其衍生物则通过抑制血管生成来抑制肿瘤的发生。这些报道表明,血管生成可能在肿瘤的发生中起重要作用。在临床环境中,血管生成对肿瘤的生长和转移至关重要。1)以结肠癌细胞、结肠癌肝转移细胞和人肝细胞癌为研究对象,探讨血管生成因子与血管内皮细胞(EA-HY 926)增殖活性的关系,明确TNT-α是否具有抑制血管生成的作用。2)采用E26转化特异性蛋白-1(ETS-1)扩散箱法检测人肝癌细胞系PLC/PRF/5(Alexander)血管生成活性。结论1)结肠癌细胞和转移细胞的平均增殖活性分别为142%和L52%。虽然不排除存在其他因素,但结肠癌细胞在原癌细胞中产生了血管生成因子,在转移细胞中产生了碱性成纤维细胞生长因子等血管生成因子。2)弥散小室法检测Alexander细胞促进新生血管生成,新生血管内皮细胞表达Ets-1。提示肝细胞癌具有较强的血管生成增殖活性,Ets-1可能在血管生成中起重要作用。
英文摘要
BackgroundRecently, it has been reported that a certain carcinogenetic promoter has an angiogenetic activity while retinoid and derivatives from vitamin D3 inhibit carcinogenesis thorough depression of angiogenesis. These reports indicate that angiogenesis may play an important role on carcinogenesis. In clinical settings, angiogenesis is crucial for tumor growth and metastasis. Thus, we investigate the following.Aims1) to examine relationship between angiogenetic factors and proliferative activity for vascular endothelium (EA-HY 926) using colon cancer cells, metastastatic cells of colon cancer to liver, and cells of human hepatocellular carcinoma, and to clarify whether TNT-alpha is able to inhibit angiogenesis or not2) to investigate the angiogenetic activity of PLC/PRF/5 (Alexander) cells, which is a human hepatoma cell line, with diffusion chamber assay using E 26 transformation-specific-1 (Ets-1)Results and Conclusion1) Mean proliferative activity of colon cancer cells and metastasized cells was l42 %, and l52 %, respectively. Although it was not ruled out of the possibility that there were other factors, colon cancer cells produced angiogenetic factors such as VEGF in original cancer cells and bFGF in the metastasized cells. TNF-alpha was not effective on inhibition of angiogenesis.2) Alexander cells accelerate angiogenesis in diffusion chamber assay and Ets- 1 was positive in the endothelium of the new vessels. These results suggest that hepatocellular carcinoma has strong proliferative activity for angiogenesis and Ets- 1 may play an important role on angiogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of transplantable self-regenerative liver tissue consisted of hepatocytes and stem cells
  • 批准号:
    21659307
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.16万
  • 财政年份:
    2009
  • 负责人:
    KANEMATSU Takashi
  • 依托单位:
Studies on the role of PRIP in insulin secretion
  • 批准号:
    18390494
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.55万
  • 财政年份:
    2006
  • 负责人:
    KANEMATSU Takashi
  • 依托单位:
Analysis of the molecular mechanisms of GABA_A receptor assembly and trafficking.
  • 批准号:
    15591969
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.37万
  • 财政年份:
    2003
  • 负责人:
    KANEMATSU Takashi
  • 依托单位:
Development of hepatocyte bank and hepatocyte transplantation with Decoy receptor 3 gene transfer
  • 批准号:
    15390381
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $6.85万
  • 财政年份:
    2003
  • 负责人:
    KANEMATSU Takashi
  • 依托单位:
国内基金
海外基金
纸箱生产线多设备PLC协同控制与智能优化系统研发
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    许昌亮
  • 依托单位:
面向化工产线自动化的PLC控制软件开发
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    徐洪焱
  • 依托单位:
基于PLC与机器视觉的嵌件注塑工艺动态调控与缺陷检测技术研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    毕昆
  • 依托单位: